185490.KQ - EyeGene Inc.

KOSDAQ - KOSDAQ Delayed Price. Currency in KRW
Currency in KRW

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.96
52-Week Change 3-64.55%
S&P500 52-Week Change 32.54%
52 Week High 312,500.00
52 Week Low 34,140.00
50-Day Moving Average 34,570.60
200-Day Moving Average 36,093.60

Share Statistics

Avg Vol (3 month) 3124.05k
Avg Vol (10 day) 357.2k
Shares Outstanding 510.99M
Implied Shares Outstanding 6N/A
Float 819.29M
% Held by Insiders 110.20%
% Held by Institutions 11.78%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21.2:1
Last Split Date 3Jun 28, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Sept 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-700.01%

Management Effectiveness

Return on Assets (ttm)-19.66%
Return on Equity (ttm)-50.85%

Income Statement

Revenue (ttm)4.73B
Revenue Per Share (ttm)220.86
Quarterly Revenue Growth (yoy)91.10%
Gross Profit (ttm)1.47B
EBITDA -31.91B
Net Income Avi to Common (ttm)-46.33B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)71.05B
Total Cash Per Share (mrq)3,308.14
Total Debt (mrq)2.4B
Total Debt/Equity (mrq)3.35
Current Ratio (mrq)13.04
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-26.61B
Levered Free Cash Flow (ttm)-19.52B